NewsResumption of Operations of Chloroprene Rubber Production Facility after Pipe Burst Accident at Omi Plant
NewsInterim Report on the Investigation of the Chloroprene Monomer Production Equipment Accident (Japanese)
NewsPublication of Interim Report of the Pipe Burst Accident at Omi Plant
NewsDenka Selected as a "Most Liked!" IR Award Winner in the 2023 IR Award
IR InformationFY2023 Second Quarter Financial Results Presentation Summary of Q&A Session
News(Disclosure Update) Notice Regarding Establishment of Joint Venture Company to Manufacture and Sell Acetylene Black and Investment in Construction of Production Plant
IR InformationFY2023 Second Quarter Financial Results Presentation Materials
IR InformationFY2023 Second Quarter Summary of Consolidated Financial Statements
NewsTemporary Suspension of ISO 9001 Certification at an Equity-Method Affiliate of Denka
NewsNotice Regarding Establishment of Joint Venture Company to Manufacture and Sell Acetylene Black and Investment in Construction of Production Plant
NewsVLPT Japan, Biken Foundation, Denka sign agreement to develop self-amplifying "replicon" RNA influenza vaccine
NewsNotice of Formulation of a Human Rights Policy of the Denka Group
IR InformationFY2023 First Quarter Financial Results Presentation Summary of Q&A Session
NewsGrant-in-Aid to be Issued under METI’s Plan to Secure Supply of Storage Batteries
IR InformationFY2023 First Quarter Financial Results Presentation Materials
IR InformationFY2023 First Quarter Summary of Consolidated Financial Statements
NewsNotice Concerning Signing of UN Global Compact
NewsFormation of Accident Investigative Committee Concerning the Pipe Burst Accident at Omi Plant
NewsNotice Concerning an Accident at Omi Plant
NewsJoint R&D and Facility Installation Agreement with Transform Materials to Establish a Low-Carbon Acetylene Supply Chain
NewsImproprieties Related to Third-Party Certification of Resin Products of Denka and an Equity-Method Affiliate, etc., and Establishment of an External Investigation Committee Consisting of Outside Experts
IR InformationNotice of Convocation of the 164th Ordinary General Meeting of Shareholders Other Matters Subject to the Electronic Provision
IR InformationNotice of Convocation of the 164th Ordinary General Meeting of Shareholders
IR InformationFY2022 Financial Results Presentation Summary of Q&A Session
IR InformationFY2022 Financial Results Presentation Topics (Launch of Mission 2030 Management Plan and Growth Strategy for Silicon Nitride and G47Δ, Oncolytic Herpes Virus)
IR InformationFY2022 Financial Results Presentation Materials
IR InformationFY2022 Summary of Consolidated Financial Statements
NewsSocial Adoption of an Invasive Endoscopic Procedure Simulator — Medical Rising STAR® project, an industry-academia collaboration between Denka and Tohoku University —
NewsU.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (9th Report) – Status of Lawsuit Seeking Review of Toxicity Assessment of Chloroprene Monomer by EPA –
NewsDenka Decides to Invest in Production Capacity Reinforcement of G47Δ, Oncolytic Herpes Simplex Virus Type 1 Product - A Strategic Investment of Approx. 12 Billion Yen to Meet Expected Growth in Demand -
NewsU.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (8th Report) – The U.S. Department of Justice (DOJ) files a legal action seeking emission reduction measures from DPE –
IR InformationFY2022 Third Quarter Financial Results Presentation Summary of Q&A Session
IR InformationFY2022 Third Quarter Financial Results Presentation Materials
IR InformationNotice Regarding Personnel Changes in Representative Directors and Executive Officers
IR InformationFY2022 Third Quarter Summary of Consolidated Financial Statements
NewsDenka Develops “PLATIECO®”, an Eco-friendly Sustainable Plastic — Containing Naturally-derived Eggshell to Contribute to the Reduction of Plastic Use and Greenhouse Gases —
NewsSigning Ceremony Held for Establishment of CVC (Corporate Venture Capital)
NewsU.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (7th Report) – Lawsuit Filed Against EPA for Correction of Toxicity Assessment Based on Latest Science –
IR InformationNotice Regarding Revisions to Consolidated Financial Results Forecast and Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2023
NewsNotice Regarding End of Commissioned Manufacturing of Macromolecular Sodium Hyaluronate
NewsNew Year’s Message
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.
